10
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6561 | Laquinimod | LAQ,ABR-215062 | Apoptosis , Others , NF-κB |
Laquinimod (LAQ) is an effective immunomodulator, which is currently under development in phase III trials for the treatment of multiple sclerosis as an oral therapy. | |||
T12177 | Natalizumab | Integrin | |
Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. | |||
TP2315 | Glatiramer Acetate | Others | |
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS). | |||
TQ0291 | Firategrast | SB 683699 | Integrin |
Firategrast (SB 683699) is an orally active and specific α4β1/α4β7 integrin antagonist.Firategrast reduces the transport of lymphocytes into the central nervous system (CNS) and decreases multiple sclerosis (MS) activity... | |||
TP1282 | PLP (139-151) | PLP 139-151 | |
PLP (139-151) is amino acid residue residue 139 to 151 of myelin proteolipid protein (PLP). This peptide is used to induce relapsing-remitting (RR)-EAE model. | |||
T78541 | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA | MOG (35-55) (TFA) | |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA, a minor constituent of central nervous system (CNS) myelin, demonstrates encephalitogenic properties by inducing T cell proliferation and... | |||
T38183 | C18 3'-sulfo Galactosylceramide (d18:1/18:0) | C18 3'-sulfo Galactosylceramide (d18:1/18:0) | |
C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in bra... | |||
T78542 | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate | MOG (35-55) (acetate) | |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) acetate, a minor component of CNS myelin, exhibits encephalitogenic activity by inducing T cell proliferation and a Th1 cytokine response, alo... | |||
T61607 | Laquinimod sodium | ||
Laquinimod (ABR-215062) sodium is a carboxamide derivative administered orally that serves as a powerful immunomodulator, designed to prevent inflammation and neurodegeneration within the central nervous system. This com... | |||
T83772 | 1-Linoleoyl Lysophosphatidic Acid sodium | 1-Linoleoyl-2-hydroxy-sn-glycero-3-PA,LPA(18:2),PA(18:2(9Z,12Z)/0:0),1-Octadecadienoyl-2-hydroxy-sn-glycero-3-phosphate,18:2 Lyso PA,1-Octadecadienoyl-2-hydroxy-sn-glycero-3-PA,PA(18:2/0:0),1-Linoleoyl-2-hydroxy-sn-glycero-3-phosphate,1-Linoleoyl LPA | |
1-Linoleoyl lysophosphatidic acid (1-linoleoyl LPA), a glycerophospholipid with linoleic acid at its sn-1 position, acts as an LPA2 receptor agonist and is the predominant LPA form in both mouse and human plasma. This co... |